Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013.
To characterize the prevalence of Type 2 diabetes between 1991 and 2013 in the UK and to determine whether corresponding glucose control and survival had changed in the diabetic population during this period.



For this retrospective cohort study, people diagnosed with Type 2 diabetes between 1991 and 2013 were identified from the Clinical Practice Research Datalink (CPRD) and the annual point prevalence calculated. Mean HbA1cby year was estimated. The Cox proportional hazards model was used to calculate the risk of all-cause mortality by year for incident cases of Type 2 diabetes treated with glucose-lowering therapy.



Crude prevalence of diagnosed Type 2 diabetes increased from 1.32% [95% confidence interval (95% CI) 1.30% to 1.34%] in 1991 to 4.54% (4.52% to 4.56%) in 2013. Mean HbA1cfor people with diagnosed Type 2 diabetes was 71 mmol/mol (8.6%) in 1991, 59 mmol/mol (7.5%) in 2003 and 58 mmol/mol (7.5%) in 2013. For diagnosed Type 2 diabetes treated with glucose-lowering therapy, when compared with 1991, the hazard ratio for all-cause mortality was 0.33 (0.27-0.41) in 2013.



The prevalence of diagnosed Type 2 diabetes trebled in the UK between 1991 and 2013. Improved survival in people with diagnosed Type 2 diabetes is likely to account, at least in part, for the increase in prevalence observed.
The Institute of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.|Global Epidemiology, Pharmatelligence, Cardiff, UK.
S E
SE
Holden
Global Epidemiology, Pharmatelligence, Cardiff, UK.
S
S
Jenkins-Jones
Global Epidemiology, Pharmatelligence, Cardiff, UK.
C Ll
CL
Morgan
Department of Medicine, University Hospital of Wales, Cardiff, UK.
J R
JR
Peters
Department of Medicine, Rudolfstiftung Hospital Vienna, Vienna, Austria.
G
G
Schernthaner
The Institute of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.|Global Epidemiology, Pharmatelligence, Cardiff, UK.
C J
CJ
Currie
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012189:Retrospective Studies; D016019:Survival Analysis; D006113:United Kingdom / Q000453:epidemiology
D001786:Blood Glucose; D006442:Glycated Hemoglobin